Privacy Policy

Small Talk Events P/L provides conference management services in accordance with the following Privacy Policy.

Small Talk Events is committed to treating the Personal Information we collect in accordance with the Australian Privacy Principles in the Privacy Act 1988 (Cth) (Privacy Act ). This Privacy Policy sets out how Small Talk Events handles Personal Information.

This Privacy Policy does not apply to Personal Information collected by Small Talk Events that is exempted under the Privacy Act

Small Talk Events may modify this Privacy Policy from time to time to reflect its current privacy practices.

In this Privacy Policy, ‘Small Talk Events’, ‘we’, ‘us’ and ‘our’ is a reference to Small Talk Events Pty Ltd. ‘Personal Information’ means any information that identifies or can be used to identify you, directly or indirectly, including, but not limited to, first and last name, place of work, email address, occupation or other demographic information.

Select a section

1. Personal Information we collect 
2. How we collect and manage Personal Information  3. Direct marketing 
4. Privacy on our websites 5. Children
6. Gaining access to Personal Information we hold 
7. Keeping Personal Information current 
8. Deleting Personal Information 
9. Complaints 
10. How to contact us 
11. Privacy Policy printable version

1. Personal Information We Collect

The types of Personal Information we collect include:

  • information about your use of this website (including time and date of access, Internet Protocol (IP) address of your computer, pages viewed, and materials downloaded);
  • information in identification documents (for example, passport, driver’s licence);
  • information that you provide for the purpose of registering through the website (including your name and address, job title, email address, phone and fax numbers);
  • information about transactions carried out over this website (including requests for services and transactions carried out through our secure payment gateway); and
  • any other information that you send to Small Talk Events.

Small Talk Events will not normally collect sensitive information such as your race, ethnic origin, politics, religion, trade union membership, genetics, biometrics (where used for ID purposes), health, sex life or sexual orientation. If an engagement requires collection of such details, specific consent will be requested from you.

It is generally not practical to remain anonymous or to use a pseudonym when dealing with Small Talk Events as usually we need to use your Personal Information to provide specific services to you, or which relate to or involve you.
Back to top

2. How we collect and manage Personal Information

2.1 How we collect Personal Information

Generally we collect your Personal Information from you directly (for example, when we deal with you in person or over the phone, when you send us correspondence (including via email), or when you use our website).

Sometimes it may be necessary for us to collect your Personal Information from a third party. For example, we may collect your Personal Information from a colleague who wishes to apply for membership of a Society on your behalf.

We may also collect Personal Information about you from your use of our websites and information you provide to us through contact mailboxes or through a registration process on our websites.
Back to top

2.2 Where you provide us with Personal Information about someone else

If you provide us with someone else’s Personal Information, you should only do so if you have their authority or consent to provide us with their Personal Information. You should also take reasonable steps to inform them of the matters set out in this Privacy Policy or any Privacy Collection Statement we give you.
Back to top

2.3 Holding Personal Information

We take reasonable and appropriate measures to protect Personal Information from loss, misuse and unauthorised access, disclosure, alteration and destruction, taking into account the risks involved in the processing and the nature of the Personal Information. In some cases, Small Talk Events engages third parties to host electronic data (including data in relation to the services we provide) on our behalf.

Our credit card processing vendors use security measures to protect your information both during the transaction and after it is complete. Our vendors are certified as compliant with PCI DSS (Payment Card Industry Data Security Standards), a set of comprehensive requirements all businesses that handle credit and debit payments must comply with.

We will retain your information for as long as your subscription is active or as long as needed to provide you with our Services. We may also retain and use your information in order to comply with our legal obligations, resolve disputes, prevent abuse, and enforce our Agreements.

If a security breach causes an unauthorised intrusion into our system that materially affects you then we will notify you and the relevant authorities within 72 hours of our becoming aware of the breach and later report the action we took in response.
Back to top

2.4 Purpose for collecting, holding, using and disclosing Personal Information

Small Talk Events collects, holds and uses Personal Information for a number of purposes including:

  • to provide professional services;
  • to provide technology services and solutions;
  • to respond to requests or queries;
  • to administer this website;
  • to personalise the website for you;
  • to enable your access to and use of the website services;
  • to verify your identity;
  • for seeking your feedback;
  • to meet any regulatory obligations;
  • to transfer your information in the case of a sale, merger, consolidation, liquidation, reorganisation, or acquisition;
  • for administrative purposes, including processing payment transactions;
  • to perform internal statistical analysis, including of our databases and website; and
  • for any other business related purposes.

If you do not provide us with the Personal Information we have requested, we may not be able to complete or fulfil the purpose for which such information was collected, including providing you or our clients with the services we were engaged to perform.

The types of third parties to whom we may disclose your Personal Information include:

  • experts or other third parties contracted as part of an engagement;
  • our agents, contractors and external service providers;
  • our professional advisers; or
  • government or regulatory bodies or agencies (for example, the Australian Taxation Office).

We do not disclose Personal Information to third parties for the purpose of allowing them to send marketing material to you. However, we may share non personal, de-identified or aggregated information with them for research or promotional purposes.
Back to top

2.5 Disclosure of Personal Information overseas and sharing Personal Information

Depending on the nature of the engagement or circumstances of collection, we may disclose your Personal Information to other entities overseas to fulfil the purpose for which the Personal Information was collected, or a related or ancillary purpose or otherwise in accordance with the Privacy Act. The countries to which such disclosures are made, and types of Personal Information disclosed, depend on the specific circumstances of the engagement.

Our servers are primarily located in Singapore. In addition, we or our subcontractors, may use cloud technology to store or process Personal Information, which may result in storage of data outside Australia. It is not practicable for us to specify in advance which country will have jurisdiction over this type of off-shore activity. All of our subcontractors, however, where relevant are required to comply with the Privacy Act in relation to the transfer or storage of Personal Information overseas.
Back to top

3. Marketing

We will not use or disclose Personal Information for the purpose of our direct marketing to you unless: you have consented to receive direct marketing; you would reasonably expect us to use your personal details for the marketing; or we believe you may be interested in the material but it is impractical for us to obtain your consent. You may opt out of any marketing materials we send to you through an unsubscribe mechanism or by contacting us directly. If you have requested not to receive further direct marketing messages, we may continue to provide you with messages that are not regarded as “direct marketing” under the Privacy Act, including changes to our terms, system alerts, and other information related to your subscription.

Small Talk Events may also use your Personal Information for the purpose of providing information about the Society or an event for which you have provided your information.

If you do not want to receive any such material from us, you can contact us as detailed below:

  • for electronic communications, you can click on the unsubscribe function in the communication or
  • for hard copy communications, you can email us or
  • use the contact details provided here.
Back to top

4. Privacy on our Websites

4.1 Automatic collection of Personal Information

Cookies and other technologies may be used by Small Talk Events and its service providers on some Small Talk Events websites and through email to automatically collect certain types of information. The collection of this information allows us to customise your online experience, improve the performance, usability and effectiveness of Small Talk Events’ online presence and to measure the effectiveness of our marketing activities.

If you register or log into a Small Talk Events web site and provide information about your preferences, we may use your information to personalise your user experience. If you register or log into a Small Talk Events web site using a third party account (such as LinkedIn, Google or Twitter), we may collect any information you have permitted the third party service to share, including your name and email address, depending on the privacy settings you have set with the third party service and their privacy policy.
Back to top

4.1.1 IP address

An IP address is a number assigned to your computer whenever you access the internet. It allows computers and servers to recognise and communicate with one another. Public IP addresses from which visitors appear to originate may be recorded for IT security and system diagnostic purposes. This information may also be used in aggregate form to conduct web site trend and performance analysis, and to personalise your user experience.
Back to top

4.1.2 Cookies

Cookies may be placed on your computer or internet-enabled device whenever you visit us online. This allows the site to remember your computer or device and serves a number of purposes.

Although most browsers automatically accept cookies, you can choose whether or not to accept cookies via your browser’s settings (often found in your browser’s Tools or Preferences menu). You may also delete cookies from your device at any time. However, please be aware that if you do not accept cookies, you may not be able to fully experience some of our web sites’ features.

Cookies by themselves do not tell us your email address or otherwise identify you personally. In our analytical reports, we may obtain other identifiers including public IP addresses, but this is for the purpose of identifying the number of unique visitors to our web sites and geographic origin of visitor trends, and not to identify individual visitors.
Back to top

4.1.3 Analytics Tools

Small Talk Events may use analytics tools, such as Google Analytics. To provide website visitors with more choice on how their data is collected by Google Analytics, Google have developed the Google Analytics Opt-out Browser Add-on . The add-on communicates with the Google Analytics JavaScript (ga.js) to indicate that information about the website visit should not be sent to Google Analytics. The Google Analytics Opt-out Browser Add-on does not prevent information from being sent to the website itself or to other web analytics services.
Back to top

4.1.4 Embedded Links

In some of our newsletters and other communications, we may monitor recipient actions such as email open rates through embedded links within the messages. We collect this information to gauge user interest and to enhance future user experiences.
Back to top

4.1.5 Social media widgets and applications

Small Talk Events web sites may include functionality to enable sharing via third party social media applications, such as the Facebook Like button and Twitter widget. These social media applications may collect and use information regarding your use of Small Talk Events web sites. Any Personal Information that you provide via such social media applications may be collected and used by other members of that social media application and such interactions are governed by the privacy policies of the companies that provide the application. We do not have control over, or responsibility for, those companies or their use of your information.

In addition, Small Talk Events web sites may host blogs, forums and other applications or services (collectively “social media features”). The purpose of social media features is to facilitate the sharing of knowledge and content. Any Personal Information that you provide on any Small Talk Events social media feature may be shared with other users of that social media feature (unless otherwise stated at the point of collection), over whom we may have limited or no control.
Back to top

4.2 Links to third party websites

Small Talk Events’ websites may contain links to third parties’ websites. Those other websites are not subject to our privacy policy and procedures. You will need to review those websites to view a copy of their privacy policy.

Small Talk Events also does not endorse, approve or recommend the services or products provided on third party websites.
Back to top

4.3 Your choices

You have several choices regarding your use of Small Talk Events’ websites. In general, you are not required to provide Personal Information when you visit our websites. However, if you apply to receive information about our services, events and industry updates or wish to join a Society or register for an event, provision of certain Personal Information will generally be required.
Back to top

5. Children

We understand the importance of protecting children’s privacy, especially in an online environment.

In particular, our websites are not intentionally designed for or directed at children under the age of 18.

It is our policy to never knowingly collect or maintain information about anyone under the age of 18, except as part of a specific engagement to provide services which necessitates such Personal Information be collected.
Back to top

6. Gaining Access to personal Information We Hold

You can request access to your Personal Information, subject to some limited exceptions permitted or required by law. Access can be provided online through the ‘Update Registration’ page on this website. Requests can also be made in writing. Please see How to contact us for details.

Small Talk Events may charge reasonable costs for providing you access to your Personal Information.
Back to top

7. Keeping Personal Information Current

We do our best to keep your data accurate and up to date, to the extent that you provide us with the information we need to do so. If your data changes (for example, if you have a new email address), then you are responsible for notifying us of those changes. If you think the information we hold about you is inaccurate, out of date, incomplete, irrelevant or misleading, we will take reasonable steps, consistent with our obligations under the Privacy Act, to correct that information upon your request. Corrections can be made online through the ‘Update Registration’ page on this website.

Corrections can also be made by contacting us, in which case we will take reasonable steps to correct it in accordance with the requirements of the Privacy Act. Please see How to contact us for details.
Back to top

8. Deleting Personal Information

You can request the permanent deletion of your Personal Information from our records at any time. Deletion requests should be made in writing, please see How to contact us for details. We will respond to such written requests within 7 business days, either by confirming that the information has been deleted or by providing reasons why deletion has not been carried out. Some information, such as financial transactions, cannot be deleted due to fiduciary or other legal obligations. Once deleted, information cannot be recovered in whole or in part.
Back to top

9. Complaints

If you wish to make a complaint to Small Talk Events about our handling of your Personal Information, you can contact us as set out in How to contact us.

Small Talk Events will endeavour to reply to you within 30 days of receipt of the complaint and, where appropriate, will advise you of the general reasons for the outcome of the complaint. In some circumstances, the Privacy Officer may decline to investigate the complaint, for example if the complaint relates to an act or practice that is not an interference of the privacy of the person making the complaint.

If you are unsatisfied with our response to a privacy matter then you may consult either an independent advisor or contact the Office of the Australian Information Commissioner for additional help. We will provide our full cooperation if you pursue this course of action.
Back to top

10. How To Contact Us

If you have a query in relation to this Privacy Policy or you would like to notify Small Talk Events that you no longer wish to receive marketing material from us, access or correct your Personal Information or to make a complaint about Small Talk Events’ handling of your Personal Information, please contact Small Talk Events as follows:

Privacy Officer
Small Talk Events
PO Box 490
West Ryde NSW 1685
T 0422 116 849
Back to top

11. Privacy Policy Printable Version

View a full version of the Small Talk Events Privacy Policy (PDF 65KB) .
Back to top

Simon Cool
Director of the UQ Advanced Cell Therapy Manufacturing Initiative, and Director of Research in the School of Chemical Engineering at the University of Queensland

Professor Cool began his scientific career at the University of Queensland over 20 years ago. He received his BSc (hons) and PhD degrees from the University of Queensland, where he subsequently held a faculty position in the School of Biomedical Sciences. His areas of study have included age-related changes in the structure of bone and teeth and the extracellular matrix compartment of skeletal tissue that guide stem cell behaviour and wound repair. Professor Cool was invited to join the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore in 2003 as a Principal Investigator. He then joined A*STAR’s Institute of Medical Biology (IMB) in 2008, shortly after its inception, to further his research in regenerative medicine, serving as Senior Principal Investigator of the Glycotherapeutics Group. In October 2020, Professor Cool re-joined the Institute of Molecular and Cell Biology (IMCB) as a Research Director, Glycotherapeutics, where he focused on developing novel glycosaminoglycan biomolecules that enhance wound repair and control adult human mesenchymal stem cell activity. Professor Cool returned to the University of Queensland, joining the School of Chemical Engineering in January 2022.

Amanda Kijas
Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Australia

Dr Amanda W. Kijas is a multidisciplinary researcher based at The University of Queensland, leading a new wound healing research program focused on interrogating the underlying science and how we can leverage this to develop innovative new approaches to wound healing products. Repurposing nature’s innovation to instruct better wound healing outcomes from the first stage of bleeding control to driving ordered and timely wound regeneration. With a focus on instructing cellular responses through the biophysical cues that act in synergy with the biochemical microenvironment to modulate these dynamic spatiotemporal cellular responses.

Kendelle Murphy
Garvan Institute of Medical Research, Australia

Dr Kendelle Murphy is a Senior Research Officer in the Cancer Invasion and Metastasis Laboratory at the Garvan Institute of Medical Research. Cancer develops in a complex three-dimensional environment, where tumour cell communication with the surrounding stroma governs cancer cell behaviour. Dr Murphy uses novel state-of-the-art intravital (in vivo, ACRF INCITe Centre) imaging approaches to provide new insights into how cells behave in a physiologically relevant environment, thereby improving our understanding of disease progression, drug delivery and efficacy. Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal disease with few treatment options. Multimodal chemotherapy regimens including gemcitabine/Abraxane and FOLFIRINOX are the current standard-of-care in the clinic, however these have limited benefits to extend survival. Focal Adhesion Kinase (FAK) is known to modulate bi-directional communication between the tumour and surrounding ECM driving disease, influencing disease progression, therapy response and the development of pro-tumorigenic fibrosis.
As a CINSW (ECR) Fellow Dr Murphy conducts research has a clear focus on clinical translation. Importantly this research led to the establishment of a Phase II clinical trial (Amplia Therapeutics Ltd, ACCENT Trial, Q3 2022), highlighting the translational and collaborative capacity of her work.

Kylie Sandy-Hodgetts
Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Australia

Kylie is Associate Professor, Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University and Honorary Senior Lecturer, School of Medicine, Cardiff University. She is Founder and President of a not-for-profit association, the International Surgical Wound Complications Advisory Panel (ISWCAP). ISWCAP’s vision is to generate awareness of surgical wound complications and improve outcomes for patients through early detection, and prevention via education and research with an international panel of experts. Kylie is a Research Scientist and Chief Investigator of several clinical trials ranging from Phase 1 first in human studies to phase 3-4 comparative effectiveness trials. Kylie’s research focuses upon early identification, prevention and management of surgical wound complications including surgical site infection (SSI) and surgical wound dehiscence (SWD). Kylie has Chaired and co-authored over 5 international clinical consensus documents, first authored over 25 original research papers and chaired the ISWCAP Best Practice Statement on the early identification and prevention of surgical wound complications. She is a reviewer for peer reviewed journals and sits on several journal editorial boards.
She is a Past Chair of the Board of Wounds Australia and has served on several national and international boards including the World Union of Wound Healing Societies (WUWHS) Executive Board as Recorder and the Scientific and Ethics Committee. Kylie Chaired the Australian National Steering Committee Surgical Wounds Panel and Wound Research Directory for the Australian Health Research Alliance National Wound Care Initiative (2020-2023). She was acknowledged internationally for her contribution to the field of surgical site infection prevention as the 2021 Winner of the Journal of Wound Care World Union Innovation in Surgical Site Infection Award.

Fiona Wood
UWA Medical School, University of Western Australia, Australia

Winthrop Professor Fiona Wood University of Western Australia is a Plastic & Reconstructive Surgeon specialising in the field of burn care, trauma, and scar reconstruction. As Director of the WA Burns Service of Western Australia since 1991 she is consultant surgeon at both the South Metropolitan Heath Service, Fiona Stanley Hospital and the Child and Adolescent Health Service, Perth Children’s Hospital. As director of burns injury research unit she leads an interdisciplinary team with broad collaboration focused on translation to improve clinical outcomes. She sits on the national science and technology council and was Australian of the year in 2005.

Khoon Lim
School of Medical Sciences, University of Sydney, Australia

Khoon is a biomedical engineer with specialization in polymer chemistry. He completed a concurrent degree – Bachelors (Hons 1) in Chemical Engineering and Masters in Biomedical Engineering, followed by a PhD in Biomedical Engineering (graduated 2014) from the University of New South Wales. He then went to join the Department of Orthopedic Surgery and Musculoskeletal Medicine at the University of Otago Christchurch in New Zealand for a postdoctoral fellowship, where he established the Light Activated Biomaterials (LAB) research group in 2019. In 2022, he joined the University of Sydney.
His research focus is on adopting a class of polymers known as hydrogels as tissue engineering matrices for a variety of applications. His has developed a number of research technology platforms, primarily using photo-polymerizable hydrogel bioinks for 3D bioprinting of functional tissues and also delivery of bioactive molecules to promote tissue regeneration. He has successfully raised a total of >$8M research grant funding ($6.5M as lead CI). He has been awarded a number of New Zealand’s most prestigious grants and fellowships, including the MARSDEN Fast Start Grant and Rutherford Discovery Fellowship from the Royal Society of New Zealand, as well as the Emerging Researcher First Grant, Sir Charles Hercus Health Research Fellowship and Project Grant from the Health Research Council of New Zealand. Since his move to Australia, he has been successful in attracting funding in a number of prestigious schemes, including the NSW Health Cardiovascular Elite Grant and the Australian Research Council Future Fellowship.

Ferry Melchels
Future Industries Institute, University of South Australia, Australia

Ferry Melchels is the research professor of Biomaterials and Tissue Engineering at the Future Industries Institute at UniSA (Mawson Lakes campus). His main interests lie in polymeric biomaterials for 3D printing, tissue engineering, and drug and vaccine delivery. His work has been published in leading journals, attracting over 16,000 citations. He is a recipient of the Patrick Neill Medal for Early Career Researchers in the Life Sciences from the Royal Society of Edinburgh, and the Mid-Career Investigator Award from the International Society for Biofabrication.
Ferry holds an MSc (2005) in chemical engineering and PhD (2010) in biomaterials from the University of Twente (The Netherlands). He was a Marie Curie post-doctoral fellow between two of the pioneering institutes in Biofabrication; Queensland University of Technology (Brisbane, Australia) and University Medical Center Utrecht (The Netherlands) and held his first PI position at Heriot-Watt University in Edinburgh (UK) from 2015-2023. Besides home brewing the best beers on the weekend, his future aim is to continue advancing materials-based technology platforms for biomedical applications.

Clair Baldock
Professor of Biochemistry at the Manchester Cell-Matrix Centre, University of Manchester, UK

Clair Baldock is a Professor of Biochemistry at the University of Manchester and Group Leader in the Manchester Cell-Matrix Centre. After a PhD in X-ray crystallography at the University of Sheffield, Clair was awarded a Royal Society Study Visit to the University of Auckland to develop further skills in protein biochemistry and molecular biology in Professor Ted Baker’s group. Following this, Clair completed postdoctoral training in the group of Professor Cay Kielty at the University of Manchester and was subsequently awarded a Royal Society Olga Kennard Research Fellowship in 2001 to establish her independent research group with focus on the structure and function of cell-matrix assemblies and complexes, in particular elastic fibre proteins fibrillin and tropoelastin. In 2007, Clair was awarded a tenured position at the University of Manchester where her research group continues to focus on the extracellular regulation of growth factor signalling using a combination of structural, cell biological and biochemical approaches. Recently, her team has determined the structure of fibrillin microfibrils from mammalian tissue using cryo-electron microscopy to reveal the consequence of pathogenic mutations on latent TGFβ binding.

Jennifer Young
Mechanobiology Institute, National University of Singapore, Singapore

Jennifer Young was trained as a biomedical engineer at the University of California, San Diego. During her Ph.D. with Prof. Adam Engler, she studied the role of mechanics in cardiac development, and created a hydrogel system capable of mimicking dynamic tissue properties in vitro. Inspired by the role of extracellular matrix (ECM) in dictating cell behaviour and fate, she joined the Cellular Biophysics group of Prof. Joachim Spatz at the Max Planck Institute for Medical Research (Heidelberg, Germany) to study the contribution of nanoscale ECM cues to cellular function. There, she discovered that variations in nanoscale ligand presentation alone affect chemoresistance in breast cancer cells, which has great implications in cancer treatment strategies. Currently she is at the Mechanobiology Institute and Biomedical Engineering Department at the National University of Singapore where her work focuses on identifying and mimicking micro-to-nanoscale matrix properties and unravelling their contributions to cellular behaviour in a diverse set of biological environments.

Andrew Holle
Mechanobiology Institute, National University of Singapore, Singapore

Andrew Holle received a Bachelor of Science, Engineering (B.S.E) from Arizona State University, where he worked in labs of Dr. Christine Pauken and Dr. Deirdre Meldrum. He then received his Ph.D. at the University of California, San Diego, where he worked in Dr. Adam Engler’s Stem Cell Biology and Bioengineering group. There, he identified the mechanosensitive role of the focal adhesion protein vinculin in substrate stiffness-induced stem cell differentiation. Looking to explore the commonalities between stem cell and cancer mechanobiology, he then joined Prof. Joachim Spatz’s Cellular Biophysics group at the Max Planck Institute for Medical Research (Stuttgart, Germany). There, he used photolithography and microfluidics to build microchannel assays to better characterize cancer cell invasion and migration in confinement. His Confinement Mechanobiology lab at the Mechanobiology Institute and in the NUS Biomedical Engineering department focuses on the role of confinement in mechanobiology, with an emphasis on novel strategies for controlling stem cell differentiation.

Alexander Nyström
Department of Dermatology, Medical Center – University of Freiburg, Freiburg, Germany

Dr Nyström’s main focus is the extracellular matrix and the dermal microenvironment in homeostasis and as initiator and driver of chronic wounds, fibrosis and cancer. To understand the multifaceted roles of the extracellular matrix, its specific components and their deficiencies play in these processes, it is necessary to go beyond the skin. Dr Nyström has an interest in the monogenetic skin blistering disorder dystrophic epidermolysis bullosa (DEB) (caused by deficiency of type VII collagen). People with DEB develop chronic wounds, progressive soft tissue fibrosis and aggressive SCCs at an early age. My group uses the disease as a model to delineate mechanisms for orphan genetic and common acquired disorders. Consequently, part of our research is focused on development of causative and evidence-based symptom-relief therapies for DEB. The aim is that some of these therapies can also be applied to common acquired wound healing pathologies.
Dr Nyström studied biochemistry and molecular biology at Lund University, Sweden and obtained a doctoral degree from the same university for studies on laminins in health and acquired and genetic diseases in the laboratory of the late Dr. Peter Ekblom. After postdoctoral work on proteoglycans in the laboratory of Dr. Renato Iozzo at the Thomas Jefferson University in Philadelphia, following Dr Nyström moved to the laboratory of Dr. Bruckner-Tuderman Freiburg, Germany to focus his research on skin biology. Since 2013 Alexander has his own independent research group at the Department of Dermatology, Medical Center – University of Freiburg, Freiburg Germany.

Claudia Loebel
Assistant Professor of Materials Science & Engineering at the University of Michigan, USA

Claudia Loebel, M.D. Ph.D., is an Assistant Professor of Materials Science & Engineering and a Biological Sciences Scholar at the University of Michigan, US. She obtained her MD (2011) at the Martin-Luther University Halle-Wittenberg in Germany and PhD (2016) at ETH Zurich (Switzerland) and completed a postdoctoral fellowship in the laboratory of Professor Jason Burdick at the University of Pennsylvania. Her research involves the development of metabolic labelling approached and biomaterial platforms to characterize and uncover the role of nascent matrix microenvironments on cell and tissue function. The applications of this research range from guiding lung alveolar stem/progenitor cell fate through material cues to developing engineered platforms for tissue repair and therapeutic treatment. Claudia Loebel is currently serving as an Associate Editor of the Wiley Journal of Biomedical Materials Research Part A (JBMRA). She was awarded the 2023 David and Lucile Packard Foundation Fellowship for her work on cell-matrix interactions, and the Pathway to Independence Award (K99/R00) through the National Heart, Lung, and Blood Institute at NIH and the Innovator Award through the American Lung Association to probe mechanisms of alveolar epithelial cell dysfunction.

Yuval Rinkevich
Director of the Helmholtz Institute of Regenerative Biology and Medicine at the Helmholtz Center, Munich, Germany

Dr. Rinkevich has been working at the cutting edge of our understanding of tissue/organ repair and regeneration for the last 20 years. The scientific focus of the Rinkevich lab lies in identifying principles of tissue/organ repair and regeneration, and developing a knowledge foundation for therapeutic strategies in clinical use. His lab explores the stem cells, cellular lineages and mechanisms by which tissues/organs repair and regenerate following injury.

His passion for healing responses and tissue rejuvenation can be traced throughout his career track, obtaining his PhD degree from the Technion-Israel Institute of Technology, where he studied whole body regeneration from single blood vessels in Protochordates. Dr Rinkevich moved to Stanford University in the US to join the renowned immunology lab of Prof. Irving L. Weissman, where he explored the cellular lineages and stem cells in mammalian tissue repair and regeneration. His work at Stanford projected Dr Rinkevich into the forefront of the tissue repair field for his pioneering work uncovering the role of fibroblast lineages in the transition from scarless to scar forming tissue responses.

Today Dr Rinkevich is the Director of the Helmholtz Institute of Regenerative Biology and Medicine at the Helmholtz Center, Munich, Germany. His lab continues to push forward our understanding of tissue/organ repair and regeneration. His latest work describing the fascia in tissue fibrosis in multiple organ systems is reinventing the way we look at tissue repair and regeneration, opening our minds to a revolution in antifibrotic therapy and the potential to prevent and potentially resolve fibrotic disease.

Hello world.

This is a sample box, with some sample content in it.

TEMTIA X Updates

Enter your details below to learn about the latest developments as we prepare for TEMTIA X in November.